More on Allscripts (MDRX): Q4 misses on all counts as results were hit by weaker sales, a...

|About: Allscripts Healthcare Solut... (MDRX)|By:, SA News Editor

More on Allscripts (MDRX): Q4 misses on all counts as results were hit by weaker sales, a deferred-revenue provision plus other items. Total revenue declined 9.6% Y/Y and gross margin fell to 38.8% from 45.1%. One bright spot however, was bookings - a key leading indicator for health IT firms - which came in at $180.7M, well ahead of consensus expectations. That is driving the stock higher in the post-trading session, with shares currently +6.4%.